Study of serum alkaline phosphatase calcium and urinary hydroxyproline as bone biomarkers in postmenopausal women.

Deepa S Sajjannar, Sanjeev L Sajjannar.

dc.contributor.author	Deepa S Sajjannar, Sanjeev L Sajjannar.
dc.date.accessioned	2020-01-16T09:58:19Z
dc.date.available	2020-01-16T09:58:19Z
dc.date.issued	2014-04
dc.identifier.uri	http://hdl.handle.net/123456789/1727
dc.description.abstract	Osteoporosis is a systemic skeletal disease characterized by low bone mass and micro-architectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture. Postmenopausal women due to the various hormonal factors are at increased risk. Bone mineral density (BMD) measurements are gold standard in calculating bone mass, the changes are usually late and the damage is irreversible. This study was done to evaluate the rate of bone loss in postmenopausal women by measuring Serum Total Alkaline Phosphatase (ALP	en_US
dc.language.iso	en	en_US
dc.publisher	BLDE(Deemed to be University)	en_US
dc.subject	Alkaline Phosphatase, Calcium, Hydroxyproline	en_US
dc.title	Study of serum alkaline phosphatase calcium and urinary hydroxyproline as bone biomarkers in postmenopausal women.	en_US
dc.type	Article	en_US